Ocugen, Inc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.About OCGN
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN.
CEOShankar Musunuri
CEOShankar Musunuri
Employees95
Employees95
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2013
Founded2013
Employees95
Employees95
OCGN Key Statistics
Market cap407.58M
Market cap407.58M
Price-Earnings ratio-5.68
Price-Earnings ratio-5.68
Dividend yield—
Dividend yield—
Average volume3.07M
Average volume3.07M
High today$1.32
High today$1.32
Low today$1.20
Low today$1.20
Open price$1.21
Open price$1.21
Volume3.98M
Volume3.98M
52 Week high$1.90
52 Week high$1.90
52 Week low$0.515
52 Week low$0.515
Stock Snapshot
With a market cap of 407.58M, Ocugen, Inc(OCGN) trades at $1.29. The stock has a price-to-earnings ratio of -5.68.
During the trading session on 2025-12-11, Ocugen, Inc(OCGN) shares reached a daily high of $1.32 and a low of $1.20. At a current price of $1.29, the stock is +7.5% higher than the low and still -2.3% under the high.
Trading activity shows a volume of 3.98M, compared to an average daily volume of 3.07M.
Over the past 52 weeks, Ocugen, Inc(OCGN) stock has traded between a high of $1.90 and a low of $0.52.
Over the past 52 weeks, Ocugen, Inc(OCGN) stock has traded between a high of $1.90 and a low of $0.52.
People also own
Based on the portfolios of people who own OCGN. This list is generated using Robinhood data, and it’s not a recommendation.